Literature DB >> 17077551

Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka.

Seikou Nakamura1, Toshiyuki Murakami, Junko Nakamura, Hisanori Kobayashi, Hisashi Matsuda, Masayuki Yoshikawa.   

Abstract

Three new cucurbitane-type triterpene called karavilagenins A, B, and C and five new cucurbitane-type triterpene glycosides called karavilosides I, II, III, IV, and V were isolated from the dried fruit of Sri Lanka Momordica charantia L. (Cucurbitaceae) together with two known cucurbitane-type triterpenes, 19(R)-methoxy-5beta,19-epoxycucurbita-6,23-dien-3beta,25-diol and 5,19-epoxycucurbita-6,23-diene-3,25-diol, and nine known cucurbitane-type triterpene glycosides, goyaglycosides-b, -c, and -d, and momordicosides F1, F2, G, I, K, and L. The structures of karavilagenins and karavilosides were elucidated on the basis of chemical and physicochemical evidence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077551     DOI: 10.1248/cpb.54.1545

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  15 in total

1.  Antioxidative flavonol glycosides from the flowers of Abelmouschus manihot.

Authors:  Yi Zhang; Wei He; Chunmei Li; Qiu Chen; Lifeng Han; Erwei Liu; Tao Wang
Journal:  J Nat Med       Date:  2012-03-10       Impact factor: 2.343

Review 2.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

3.  Inhibition of nuclear transcription factor-κB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia.

Authors:  Nguyen Xuan Nhiem; Pham Hai Yen; Nguyen Thi Thanh Ngan; Tran Hong Quang; Phan Van Kiem; Chau Van Minh; Bui Huu Tai; Nguyen Xuan Cuong; Seok Bean Song; Young Ho Kim
Journal:  J Med Food       Date:  2012-01-16       Impact factor: 2.786

4.  Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.

Authors:  Shuaizhen Zhou; Pierre-Marie Allard; Christian Wolfrum; Changqiang Ke; Chunping Tang; Yang Ye; Jean-Luc Wolfender
Journal:  Metabolomics       Date:  2019-07-18       Impact factor: 4.290

Review 5.  Bitter melon: antagonist to cancer.

Authors:  Pratibha Nerurkar; Ratna B Ray
Journal:  Pharm Res       Date:  2010-03-03       Impact factor: 4.200

6.  General Enantioselective and Stereochemically Divergent Four-Stage Approach to Fused Tetracyclic Terpenoid Systems.

Authors:  Joshua M Nicholson; Adam B Millham; Andrea R Bucknam; Lauren E Markham; Xenia Ivanna Sailors; Glenn C Micalizio
Journal:  J Org Chem       Date:  2022-02-17       Impact factor: 4.198

Review 7.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

Review 8.  Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome.

Authors:  Md Ashraful Alam; Riaz Uddin; Nusrat Subhan; Md Mahbubur Rahman; Preeti Jain; Hasan Mahmud Reza
Journal:  J Lipids       Date:  2015-01-12

9.  Supplementation of fresh ucche (Momordica charantia L. var. muricata Willd) prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated rats.

Authors:  Abu Taher Sagor; Mohammed Riaz Hasan Chowdhury; Nabila Tabassum; Hemayet Hossain; Md Mahbubur Rahman; Md Ashraful Alam
Journal:  BMC Complement Altern Med       Date:  2015-04-11       Impact factor: 3.659

10.  Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches.

Authors:  Temitope Isaac Adelusi; Misbaudeen Abdul-Hammed; Mukhtar Oluwaseun Idris; Oyedele Qudus Kehinde; Ibrahim Damilare Boyenle; Ukachi Chiamaka Divine; Ibrahim Olaide Adedotun; Ajayi Ayodeji Folorunsho; Oladipo Elijah Kolawole
Journal:  In Silico Pharmacol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.